Nearly six months ago, I covered Immatics ( IMTX ) as a PRAME leader moving toward commercial reality. Since then, the main changes are a stronger runway into 2028 and new ASCO 2026 updates that broaden the I have a strong inclination towards high-growth companies, often treading in sectors poised for exponential expansion. My expertise lies in understanding and investing in disruptive technologies and forward-thinking enterprises. My approach is a mix of fundamental analysis and future trend prediction. I ...